G. Pilianidis, G. Papanastasiou, P. Tikoudi, A. Themistocleous, G. Farmakis, and K. Dolianitis, “Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?”, EJCRIM, vol. 11, no. 3, Feb. 2024, doi: 10.12890/2024_004282.